mc73..
Agree with you 100%. This is my concern with the drug as well. I have been down this road before with Vivus (VVUS) and Arena (ARNA).
Both got approval for their weight loss drugs....stock soared....but both as in turns out neither company could get the drug priced right, nor could they get insurance companies to pay for their drugs.
When Belviq came out (Arena weight loss drug) the price for a month supply of the pills was $275.
Vivus weight loss drug was only for very obese patients and was also a victim of similar pricing/marketing issues.
Bottom line....both stocks tanked after about 6 months....(Look them up around 2013 or 2012)
That is what concerns me.....all that you state is correct....lots of unknowns here. Especially with the amount of. money that it will take.
If a big tobacco company doesn't buy CVSI or big Pharma doesn't buy them, then CVSI is taking on the giants...and as you said, this will involve millions of dollars....they will begin to take on debt, issue new stock for a capital raise and a whole lot of things may go wrong.
I am in very low on this stock, I would like to see $10-$15 stock price based on CBD sales alone...they have plenty of room to scale up their consumer division.
The very first piece of bad news that would come out about CVSI 007 gum would be disastrous for this stock...I have seen happen many times...
What I would really like to see is FDA GRAS approval for their CBD formula, in which their brand is private labeled for CVS or Walgreens and approval for over the counter purchase from a drug store or any store....
That is the home run.....and First to Market often wins...
Market Data 
Markets 
AI
